Page last updated: 2024-10-20

pyrazinoic acid and Seizures

pyrazinoic acid has been researched along with Seizures in 1 studies

pyrazinoic acid: active metabolite of pyrazinamide; structure
pyrazine-2-carboxylic acid : The parent compound of the class of pyrazinecarboxylic acids, that is pyrazine bearing a single carboxy substituent. The active metabolite of the antitubercular drug pyrazinamide.

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jimonet, P1
Bohme, GA1
Bouquerel, J1
Boireau, A1
Damour, D1
Debono, MW1
Genevois-Borella, A1
Hardy, JC1
Hubert, P1
Manfré, F1
Nemecek, P1
Pratt, J1
Randle, JC1
Ribeill, Y1
Stutzmann, JM1
Vuilhorgne, M1
Mignani, S1

Other Studies

1 other study available for pyrazinoic acid and Seizures

ArticleYear
Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action.
    Bioorganic & medicinal chemistry letters, 2001, Jan-22, Volume: 11, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Combinatorial Ch

2001